World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
56
Citations
22186
World Ranking
14147
National Ranking
5964

Overview

Lisa E. Gralinski is affiliated with the University of North Carolina at Chapel Hill in the United States. Their research primarily focuses on fields within Medicine, with an emphasis on Infectious Diseases, Epidemiology, Immunology, Animal Science and Zoology, and Genetics.

The main topics of their research activity include:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Animal Virus Infections Studies
  • Viral gastroenteritis research and epidemiology
  • Respiratory viral infections research
  • Interferon and immune responses
  • SARS-CoV-2 detection and testing

Frequent co-authors collaborating with Lisa E. Gralinski include:

  • Ralph S. Baric (87 joint publications)
  • Alexandra Schäfer (39 joint publications)
  • Vineet D. Menachery (38 joint publications)
  • Sarah R. Leist (35 joint publications)
  • Martin T. Ferris (29 joint publications)

Regarding publication venues, Lisa E. Gralinski has contributed extensively to:

  • UNC Libraries (52 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (16 publications)
  • Nature (5 publications)
  • Cell (4 publications)
  • Science (2 publications)

Some of the recent papers authored or co-authored by Lisa E. Gralinski include:

  • Return of the Coronavirus: 2019-nCoV (2020) in Viruses
  • SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract (2020) in Cell
  • Potently neutralizing and protective human antibodies against SARS-CoV-2 (2020) in Nature
  • SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo (2020) in Science
  • Animal models for COVID-19 (2020) in Nature

Best Publications

  • Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses

    Timothy P. Sheahan;Amy C. Sims;Rachel L. Graham;Vineet D. Menachery

  • SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract.

    Yixuan J. Hou;Kenichi Okuda;Caitlin E. Edwards;David R. Martinez

  • Return of the Coronavirus: 2019-nCoV.

    Lisa E. Gralinski;Vineet D. Menachery

  • Potently neutralizing and protective human antibodies against SARS-CoV-2.

    Seth J. Zost;Pavlo Gilchuk;James Brett Case;Elad Binshtein

  • A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence

    Vineet D. Menachery;Boyd L. Yount;Kari Debbink;Sudhakar Agnihothram

  • SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo

    Yixuan J. Hou;Shiho Chiba;Peter Halfmann;Camille Ehre

  • Animal models for COVID-19.

    César Muñoz-Fontela;William E. Dowling;Simon G.P. Funnell;Pierre S. Gsell

  • The genome architecture of the collaborative cross mouse genetic reference population

    Fuad A. Iraqi;Mustafa Mahajne;Yasser Salaymah;Hani Sandovski

  • A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.

    Kenneth H. Dinnon;Sarah R. Leist;Alexandra Schäfer;Caitlin E. Edwards

  • A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon Challenge

    Meagan Bolles;Damon Deming;Kristin Michelle Long;Sudhakar Agnihothram

  • A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice.

    Sarah R. Leist;Kenneth H. Dinnon;Alexandra Schäfer;Longping V. Tse

  • Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis

    Lisa E. Gralinski;Timothy Patrick Sheahan;Thomas E. Morrison;Vineet D. Menachery;Vineet D. Menachery

  • A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2.

    Ahmed O. Hassan;Natasha M. Kafai;Igor P. Dmitriev;Julie M. Fox

  • Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2.

    Alexandra C. Walls;Brooke Fiala;Alexandra Schäfer;Samuel Wrenn

  • Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice.

    Andrea J. Pruijssers;Andrea J. Pruijssers;Amelia S. George;Amelia S. George;Alexandra Schäfer;Sarah R. Leist

  • SARS-like WIV1-CoV poised for human emergence

    Vineet D. Menachery;Boyd L. Yount;Amy C Sims;Kari Debbink

  • Genetic analysis of complex traits in the emerging Collaborative Cross

    David L. Aylor;William Valdar;Wendy Foulds-Mathes;Ryan J. Buus

  • SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801.

    Angela Wahl;Lisa E. Gralinski;Claire E. Johnson;Wenbo Yao

  • Molecular pathology of emerging coronavirus infections

    Lisa E Gralinski;Ralph S Baric

  • Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody.

    C. Garrett Rappazzo;Longping V. Tse;Chengzi I. Kaku;Daniel Wrapp

Frequent Co-Authors

Ralph S. Baric
Ralph S. Baric University of North Carolina at Chapel Hill
Vineet D. Menachery
Vineet D. Menachery The University of Texas Medical Branch at Galveston
Alexandra Schäfer
Alexandra Schäfer Duke University
Mark T. Heise
Mark T. Heise University of North Carolina at Chapel Hill
Boyd Yount
Boyd Yount University of North Carolina at Chapel Hill
Fernando Pardo-Manuel de Villena
Fernando Pardo-Manuel de Villena University of North Carolina at Chapel Hill
Shannon K. McWeeney
Shannon K. McWeeney Oregon Health & Science University
Katrina M. Waters
Katrina M. Waters Pacific Northwest National Laboratory
Yoshihiro Kawaoka
Yoshihiro Kawaoka University of Tokyo
David R. Martinez
David R. Martinez Yale University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Lisa E. Gralinski

Trending Scientists